GSK recalls Alli in the US due to tampering

27 March 2014 - Deborah Wilkes

Archived

GlaxoSmithKline Consumer Healthcare has recalled its weight-loss medicine Alli (orlistat) in the US and Puerto Rico following product tampering.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: